BioReference Laboratories Inc. in Elmwood Park acquired the U.S. Ariosa centralized laboratory prenatal testing business from Roche. The Harmony Prenatal Test, Ariosa’s non-invasive prenatal screening ...
Similar to BioReference's role as the testing provider for the MLS is Back Tournament, BioReference is providing laboratory-based PCR COVID-19 testing as well as point-of-care (rapid) COVID-19 testing ...
ELMWOOD PARK, N.J., March 26, 2021 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced the expansion of its COVID-19 school testing program to ...
BioReference announced the acquisition of the U.S. Ariosa centralized laboratory prenatal testing business from Roche. Ariosa’s non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, ...
Elmwood Park, NJ, May 17, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health company, along with its specialty women’s health division, GenPath, today announces the launch of new ...
CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) and the U.S. Department of Health and Human Services (HHS), together with BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), ...
OPKO Health Inc.’s OPK BioReference Laboratories, Inc. and Buffalo Bills, 2020 American Football Conference (AFC) East Division Champions recently inked a deal to provide testing for fans for AFC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback